NCT01490632 2019-09-27A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisEli Lilly and CompanyPhase 2 Completed271 enrolled 32 charts
NCT01107457 2019-09-24A Study in Participants With Moderate to Severe PsoriasisEli Lilly and CompanyPhase 2 Completed142 enrolled 45 charts
NCT02908347 2019-01-23Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis PatientsMetrioPharm AGPhase 2 Completed46 enrolled 24 charts
NCT01241591 2018-12-26A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisPfizerPhase 3 Completed1,101 enrolled 46 charts
NCT02201524 2016-10-05Study to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisPfizerPhase 2 Terminated59 enrolled 18 charts